Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.5700
+0.0240 (4.40%)
Aug 15, 2025, 10:47 AM - Market open

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
Life-transforming Therapies
636.00K

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024
Period Ending
Dec '24
United States
636.00K